CR10304A - Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos - Google Patents
Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismosInfo
- Publication number
- CR10304A CR10304A CR10304A CR10304A CR10304A CR 10304 A CR10304 A CR 10304A CR 10304 A CR10304 A CR 10304A CR 10304 A CR10304 A CR 10304A CR 10304 A CR10304 A CR 10304A
- Authority
- CR
- Costa Rica
- Prior art keywords
- compounds
- tetrahydropiridotienopirimidine
- procedures
- same use
- pharmaceutical compositions
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Abstract
Esta invencion se refiere a compuestos de formula (1), en la que las variables son como se describen en la memoria descriptiva, a composiciones farmaceuticas que las contienen, a procedimientos de preparacion de los compuestos y composiciones farmaceuticas, y a procedimientos de uso de los compuestos y composiciones farmaceuticas para el tratamiento o prevencion de trastornos, de forma particular cancer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78414606P | 2006-03-20 | 2006-03-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR10304A true CR10304A (es) | 2009-01-27 |
Family
ID=38523058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR10304A CR10304A (es) | 2006-03-20 | 2008-09-19 | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US8501755B2 (es) |
| EP (1) | EP2001890B1 (es) |
| JP (1) | JP5282026B2 (es) |
| KR (1) | KR20080110834A (es) |
| CN (1) | CN101448840B (es) |
| AR (1) | AR059901A1 (es) |
| AT (1) | ATE495179T1 (es) |
| AU (1) | AU2007227317A1 (es) |
| BR (1) | BRPI0711045A2 (es) |
| CA (1) | CA2647036C (es) |
| CR (1) | CR10304A (es) |
| DE (1) | DE602007011906D1 (es) |
| DO (1) | DOP2007000053A (es) |
| EC (1) | ECSP088749A (es) |
| ES (1) | ES2357654T3 (es) |
| GT (1) | GT200800187A (es) |
| IL (1) | IL194028A0 (es) |
| MA (1) | MA30351B1 (es) |
| MX (1) | MX2008012006A (es) |
| NZ (1) | NZ571326A (es) |
| PA (1) | PA8719401A1 (es) |
| PE (1) | PE20080144A1 (es) |
| RU (1) | RU2008141239A (es) |
| SV (1) | SV2008003032A (es) |
| TN (1) | TNSN08370A1 (es) |
| TW (1) | TW200804397A (es) |
| UY (1) | UY30220A1 (es) |
| WO (1) | WO2007109279A2 (es) |
| ZA (1) | ZA200808017B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| JP5461402B2 (ja) * | 2007-09-14 | 2014-04-02 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 置換三環式化合物およびその使用方法 |
| WO2010054285A2 (en) | 2008-11-10 | 2010-05-14 | National Health Research Institutes | Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors |
| CA2861462A1 (en) * | 2012-01-25 | 2013-08-01 | Proteostasis Therapeutics, Inc. | Proteasome activity modulating tricyclic compounds |
| JP2017519737A (ja) * | 2014-05-26 | 2017-07-20 | バイエル・ファルマ・アクティエンゲゼルシャフト | 置換テトラヒドロピリドチエノピリミジン |
| EP3111960B1 (en) * | 2015-07-03 | 2019-12-11 | Kyoto University | Nuclear medicine diagnostic imaging agent |
| FI3474846T3 (fi) | 2016-06-22 | 2023-02-16 | Univ Vanderbilt | Muskariinisen asetyylikoliinireseptorin m4 positiiviset allosteeriset modulaattorit |
| CN109863139B (zh) | 2016-11-07 | 2023-02-17 | 范德比尔特大学 | 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂 |
| MA47126A (fr) | 2016-11-07 | 2019-10-30 | Univ Vanderbilt | Modulateurs allostériques positifs du récepteur muscarinique à l'acétylcholine m4 |
| EP3534901B1 (en) | 2016-11-07 | 2022-06-22 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| TW201930311A (zh) | 2017-12-05 | 2019-08-01 | 泛德比爾特大學 | 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑 |
| WO2019113174A1 (en) | 2017-12-05 | 2019-06-13 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| WO2020191151A1 (en) * | 2019-03-19 | 2020-09-24 | Oncovalent Therapeutics Inc. | Sumo inhibitor compounds and uses thereof |
| EP4380941A1 (en) * | 2021-08-05 | 2024-06-12 | Bristol-Myers Squibb Company | Tricyclic fused pyrimidine compounds for use as her2 inhibitors |
| CN114736154B (zh) * | 2022-03-15 | 2023-07-21 | 安庆朗坤药业有限公司 | N-（3-氯-4-（2-吡啶甲氧基）苯基）-2-氰基乙酰胺的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000059912A1 (en) * | 1999-03-30 | 2000-10-12 | Nippon Soda Co., Ltd. | Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
| DE19944604A1 (de) | 1999-09-17 | 2001-03-22 | Merck Patent Gmbh | Aminderivate |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| JPWO2003035653A1 (ja) * | 2001-10-26 | 2005-02-10 | 日本曹達株式会社 | ピリドチエノピリミジン化合物およびその塩 |
| WO2005010008A1 (en) * | 2003-07-24 | 2005-02-03 | Bayer Pharmaceuticals Corporation | Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders |
-
2007
- 2007-03-15 AR ARP070101057A patent/AR059901A1/es not_active Application Discontinuation
- 2007-03-19 UY UY30220A patent/UY30220A1/es not_active Application Discontinuation
- 2007-03-19 PE PE2007000292A patent/PE20080144A1/es not_active Application Discontinuation
- 2007-03-19 TW TW096109309A patent/TW200804397A/zh unknown
- 2007-03-20 BR BRPI0711045-6A patent/BRPI0711045A2/pt not_active IP Right Cessation
- 2007-03-20 DO DO2007000053A patent/DOP2007000053A/es unknown
- 2007-03-20 CN CN2007800178021A patent/CN101448840B/zh not_active Expired - Fee Related
- 2007-03-20 KR KR1020087025480A patent/KR20080110834A/ko not_active Ceased
- 2007-03-20 EP EP07753547A patent/EP2001890B1/en not_active Not-in-force
- 2007-03-20 US US12/225,285 patent/US8501755B2/en not_active Expired - Fee Related
- 2007-03-20 RU RU2008141239/04A patent/RU2008141239A/ru not_active Application Discontinuation
- 2007-03-20 AU AU2007227317A patent/AU2007227317A1/en not_active Abandoned
- 2007-03-20 PA PA20078719401A patent/PA8719401A1/es unknown
- 2007-03-20 ES ES07753547T patent/ES2357654T3/es active Active
- 2007-03-20 WO PCT/US2007/006927 patent/WO2007109279A2/en not_active Ceased
- 2007-03-20 AT AT07753547T patent/ATE495179T1/de not_active IP Right Cessation
- 2007-03-20 NZ NZ571326A patent/NZ571326A/en not_active IP Right Cessation
- 2007-03-20 CA CA2647036A patent/CA2647036C/en not_active Expired - Fee Related
- 2007-03-20 JP JP2009501517A patent/JP5282026B2/ja not_active Expired - Fee Related
- 2007-03-20 MX MX2008012006A patent/MX2008012006A/es active IP Right Grant
- 2007-03-20 DE DE602007011906T patent/DE602007011906D1/de active Active
-
2008
- 2008-09-11 IL IL194028A patent/IL194028A0/en unknown
- 2008-09-18 GT GT200800187A patent/GT200800187A/es unknown
- 2008-09-18 ZA ZA200808017A patent/ZA200808017B/xx unknown
- 2008-09-18 SV SV2008003032A patent/SV2008003032A/es not_active Application Discontinuation
- 2008-09-19 CR CR10304A patent/CR10304A/es not_active Application Discontinuation
- 2008-09-19 EC EC2008008749A patent/ECSP088749A/es unknown
- 2008-09-22 TN TNP2008000370A patent/TNSN08370A1/en unknown
- 2008-10-20 MA MA31320A patent/MA30351B1/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR10304A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
| HN2012001162A (es) | Triazolopiridinas | |
| ECSP088329A (es) | Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8 | |
| CR9834A (es) | [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la ezquizofrenia | |
| ECSP099445A (es) | Quinazolinas para la inhibición de pdk1 | |
| HN2008000311A (es) | Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida | |
| GT200800184A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes. | |
| UY31314A1 (es) | Amidas heterociclicas y sus métodos de uso-976 | |
| PA8842101A1 (es) | Heteroarilos sustituidos | |
| PA8622401A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico,procesos para su preparacion y su uso como medicamentos | |
| UY30723A1 (es) | Compuestos de biciclocarboxiamida sustituidos | |
| ECSP088763A (es) | Nuevas combinaciones terapéuticas para el tratamiento de la depresión | |
| UY32359A (es) | Compuestos de plasmalogenos, composiciones farmaceuticas que los contienen y metodos para tratar enfermedades del envejecimiento | |
| CR9663A (es) | Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
| UY31322A1 (es) | Amidas heterocíclicas y sus métodos de uso-975 | |
| CR10497A (es) | Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38 | |
| CO6341625A2 (es) | Derivados de indol como agentes anticáncer | |
| UY29414A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| UY29767A1 (es) | Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones | |
| PA8667201A1 (es) | Nuevos compuestos farmaceuticos | |
| CL2007003223A1 (es) | Compuestos derivados de piperidinil 4-arilsulfonamidas n-sustituidas, que actuan como moduladores de la proteina sfrp-1; proceso para preparar los compuestos; co mposicion farmaceutica que comprende a dichos copmpuestos y uso de los compuestos para preparar medicamentos para el tratamiento de enfermedades. | |
| GT200600161A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
| CR10255A (es) | "nuevas composiciones terapéuticas para el tratamiento o la prevención de trastornos psicóticos" | |
| UY31143A1 (es) | Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas | |
| HN2011000404A (es) | Derivados de enfumafungina y composicion comprendiendo los mismos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |